NCLT dismisses waiver plea filed by Cyrus Mistry-owned firms

Source: Vccircle In a jolt to former Tata group chairman Cyrus Mistry, the National Company Law Tribunal (NCLT) has dismissed a plea filed by two Mistry family-owned investment companies seeking a waiver from the requirement for shareholders’ approval to file a petition against Tata Sons Ltd. On Monday, a division bench of NCLT, comprising Justice [...]

April 18th, 2017|

Mazagon Dock, five public sector units to list

Source: Daily News and Analysis The government has embarked on a move to partially divest stake in six public sector units, four of which are key players in defence sector. With stock markets enjoying heightened valuations, the government is preparing to list a clutch of defence-related state-owned entities including guided missiles maker Bharat Dynamics, naval [...]

April 13th, 2017|

Luthra, CAM, DSK, Khaitan lead on True North acquisition of Religare Health Insurance

Source: Bar and Bench Religare Enterprises Ltd is selling its entire 80% stake in Religare Health Insurance Co to a consortium of investors led by private equity firm True North. This deal values Religare Health Insurance Company Limited at Rs. 1300 crores. Dalmia Group is also one of the investors and part of the consortium. [...]

April 13th, 2017|

Cyril Amarchand starts GNLU chair for ethics, vows to expand it across other universities if successful

Source: Legally India Cyril Amarchand Mangaldas has fully funded a chair in “everyday ethics for the legal profession” at GNLU Gandhinagar for at least the next three years, which, if it succeeds, would become a template for the law firm contributing financially to other universities’ courses. “We want to run the pilot course first, and [...]

April 6th, 2017|
 

DISCLAIMER

This website has been designed only for the purposes of dissemination of basic information on Cyril Amarchand Mangaldas; information which is otherwise available on the internet, various public platforms and social media. Careful attention has been given to ensure that the information provided herein is accurate and up-to-date. However, Cyril Amarchand Mangaldas is not responsible for any reliance that a reader places on such information and shall not be liable for any loss or damage caused due to any inaccuracy in or exclusion of any information, or its interpretation thereof. Reader is advised to confirm the veracity of the same from independent and expert sources.

This website is not an attempt to advertise or solicit clients, and does not seek to create or invite any lawyer-client relationship. The links provided on this website are to facilitate access to basic information on Cyril Amarchand Mangaldas, and, to share the various thought leadership initiatives undertaken by it. The content herein or on such links should not be construed as a legal reference or legal advice. Readers are advised not to act on any information contained herein or on the links and should refer to legal counsels and experts in their respective jurisdictions for further information and to determine its impact.

Cyril Amarchand Mangaldas advises against the use of the communication platform provided on this website for exchange of any confidential, business or politically sensitive information. User is requested to use his or her judgment and exchange of any such information shall be solely at the user’s risk.

Cyril Amarchand Mangaldas uses cookies on its website to improve its usability. This helps us in providing a good user experience and to also help in improving our website. By continuing to use our website without changing your privacy settings, you agree to use our cookies.